These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 10855693)
1. Isolation and characterization of the androgen receptor mutants with divergent transcriptional activity in response to hydroxyflutamide. Wang C; Young WJ; Chang C Endocrine; 2000 Feb; 12(1):69-76. PubMed ID: 10855693 [TBL] [Abstract][Full Text] [Related]
2. Dehydroepiandrosterone activates mutant androgen receptors expressed in the androgen-dependent human prostate cancer xenograft CWR22 and LNCaP cells. Tan J; Sharief Y; Hamil KG; Gregory CW; Zang DY; Sar M; Gumerlock PH; deVere White RW; Pretlow TG; Harris SE; Wilson EM; Mohler JL; French FS Mol Endocrinol; 1997 Apr; 11(4):450-9. PubMed ID: 9092797 [TBL] [Abstract][Full Text] [Related]
3. Mutations at the boundary of the hinge and ligand binding domain of the androgen receptor confer increased transactivation function. Buchanan G; Yang M; Harris JM; Nahm HS; Han G; Moore N; Bentel JM; Matusik RJ; Horsfall DJ; Marshall VR; Greenberg NM; Tilley WD Mol Endocrinol; 2001 Jan; 15(1):46-56. PubMed ID: 11145738 [TBL] [Abstract][Full Text] [Related]
6. Antiandrogens inhibit human androgen receptor-dependent gene transcription activation in the human prostate cancer cells LNCaP. Warriar N; Pagé N; Koutsilieris M; Govindan MV Prostate; 1994 Apr; 24(4):176-86. PubMed ID: 8146066 [TBL] [Abstract][Full Text] [Related]
7. Effects of antiandrogens on transformation and transcription activation of wild-type and mutated (LNCaP) androgen receptors. Berrevoets CA; Veldscholte J; Mulder E J Steroid Biochem Mol Biol; 1993 Dec; 46(6):731-6. PubMed ID: 8274406 [TBL] [Abstract][Full Text] [Related]
8. Suppression of mutant androgen receptors by flutamide. Ishioka J; Hara S; Isaacs JT; Tomura A; Nishikawa K; Kageyama Y Int J Urol; 2009 May; 16(5):516-21. PubMed ID: 19389135 [TBL] [Abstract][Full Text] [Related]
9. Androgen antagonistic effect of estramustine phosphate (EMP) metabolites on wild-type and mutated androgen receptor. Wang LG; Liu XM; Kreis W; Budman DR Biochem Pharmacol; 1998 May; 55(9):1427-33. PubMed ID: 10076535 [TBL] [Abstract][Full Text] [Related]
10. The androgen receptor T877A mutant recruits LXXLL and FXXLF peptides differently than wild-type androgen receptor in a time-resolved fluorescence resonance energy transfer assay. Ozers MS; Marks BD; Gowda K; Kupcho KR; Ervin KM; De Rosier T; Qadir N; Eliason HC; Riddle SM; Shekhani MS Biochemistry; 2007 Jan; 46(3):683-95. PubMed ID: 17223690 [TBL] [Abstract][Full Text] [Related]
11. The amino terminus of the human AR is target for corepressor action and antihormone agonism. Dotzlaw H; Moehren U; Mink S; Cato AC; Iñiguez Lluhí JA; Baniahmad A Mol Endocrinol; 2002 Apr; 16(4):661-73. PubMed ID: 11923464 [TBL] [Abstract][Full Text] [Related]
12. Functional domain and motif analyses of androgen receptor coregulator ARA70 and its differential expression in prostate cancer. Hu YC; Yeh S; Yeh SD; Sampson ER; Huang J; Li P; Hsu CL; Ting HJ; Lin HK; Wang L; Kim E; Ni J; Chang C J Biol Chem; 2004 Aug; 279(32):33438-46. PubMed ID: 15166229 [TBL] [Abstract][Full Text] [Related]
13. Novel mutations of androgen receptor: a possible mechanism of bicalutamide withdrawal syndrome. Hara T; Miyazaki J; Araki H; Yamaoka M; Kanzaki N; Kusaka M; Miyamoto M Cancer Res; 2003 Jan; 63(1):149-53. PubMed ID: 12517791 [TBL] [Abstract][Full Text] [Related]
14. Phosphorylation/dephosphorylation of androgen receptor as a determinant of androgen agonistic or antagonistic activity. Wang LG; Liu XM; Kreis W; Budman DR Biochem Biophys Res Commun; 1999 May; 259(1):21-8. PubMed ID: 10334909 [TBL] [Abstract][Full Text] [Related]
15. Study of the impact of the T877A mutation on ligand-induced helix-12 positioning of the androgen receptor resulted in design and synthesis of novel antiandrogens. Zhou J; Liu B; Geng G; Wu JH Proteins; 2010 Feb; 78(3):623-37. PubMed ID: 19787772 [TBL] [Abstract][Full Text] [Related]
16. Deoxyribonucleic acid-binding ability of androgen receptors in whole cells: implications for the actions of androgens and antiandrogens. Kuil CW; Mulder E Endocrinology; 1996 May; 137(5):1870-7. PubMed ID: 8612526 [TBL] [Abstract][Full Text] [Related]
17. Delta5-androstenediol is a natural hormone with androgenic activity in human prostate cancer cells. Miyamoto H; Yeh S; Lardy H; Messing E; Chang C Proc Natl Acad Sci U S A; 1998 Sep; 95(19):11083-8. PubMed ID: 9736693 [TBL] [Abstract][Full Text] [Related]
19. Activation of mitogen-activated protein kinase pathway by the antiandrogen hydroxyflutamide in androgen receptor-negative prostate cancer cells. Lee YF; Lin WJ; Huang J; Messing EM; Chan FL; Wilding G; Chang C Cancer Res; 2002 Nov; 62(21):6039-44. PubMed ID: 12414626 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of androgen receptor-dependent transcriptional activity by DDT isomers and methoxychlor in HepG2 human hepatoma cells. Maness SC; McDonnell DP; Gaido KW Toxicol Appl Pharmacol; 1998 Jul; 151(1):135-42. PubMed ID: 9705896 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]